feed,title,long_url,short_url
🔐MarketWatch,Athira says its Alzheimer's treatment did not meet endpoint in mid-stage trial; stock falls 68%,http://www.marketwatch.com/news/story/athira-says-its-alzheimers-treatment/story.aspx?guid=%7BAC17AC3A%2DCD5B%2D4633%2DB9C5%2D74489758ECB9%7D&siteid=rss,https://on.mktw.net/3Ok49Mo
